Table 2.

Changes in variables during the treatment period. Numbers indicate the median difference between end and beginning of treatment, presented as % of the values at beginning of treatment

Parameter	huIFN-α2a	AZT	huIFN-α2a/AZT	Placebo	P *
Stomatitis	−4.8	0.6	−8.7	1.1	0.080
Haemoglobin (g/dl)	−4.5	−9.9	−16.6	−5.7	0.265
Haematocrit (%)	−1.0	−3.1	−4.9	−1.6	0.703
WBC count (cells/µl)	2.8	−5.2	−4.7	−4.0	0.893
Relative CD4 count (%)	3.8	2.6	4.1	−4.9	0.444
Relative CD8 count (%)	−0.8	−1.6	2.4	2.2	0.443
Absolute CD4 count (cells/µl)	−2.0	−12.3	106.2	5.6	0.335
Absolute CD8 count (cells/µl)	−33.0	−22.5	96.7	63.7	0.089
CD4/CD8 ratio	23.1	66.7	−11.8	−18.2	0.192
FeLV p27 antigen	0.3	−3.6	−1.5	1.2	0.988

^*Comparison between groups by Kruskall–Wallis test

WBC = white blood cell; FeLV = feline leukaemia virus; huIFN-α2a = human interferon-α2a